Media Center
Press Releases

Press Releases

15 Feb 17
Immunology attracting high level of investment as companies seek to build on success of marketed products, says GBI Research

With a total of 2,145 products currently in development, the immunology market is experiencing a high level of investment compared to many other therapy areas, and companies working within it are seeking to build on the clinical and commercial success of marketed products such as tumor necrosis factor-alpha (TNF-a) inhibitors, according to business intelligence provider GBI Research.

Read post
14 Feb 17
Roche to gain most as Biogen remains leader in neurodegenerative drugs market by 2022, says GBI Research

Roche will be the biggest mover in the neurodegenerative drugs space over the next five years, with the anticipated approval of ocrelizumab driving the company’s share of the market from less than 1% in 2016 to approximately 15% by 2022, according to business intelligence provider GBI Research.

Read post
08 Feb 17
Digital trends are changing marketing strategies within the pharmaceutical field, says GBI Research

Changing physician, patient, and consumer trends in today’s increasingly digital society are forcing an evolution of pharmaceutical marketing strategies, according to business intelligence provider GBI Research.

Read post
01 Feb 17
Almost three-quarters of healthcare companies will invest in Big Data by 2021, says GBI Research

As the useful applications of Big Data in the pharmaceutical and healthcare sector become increasingly apparent, 73% of organizations in the industry are set to begin or increase investment in Big Data within the next five years, according to business intelligence provider GBI Research.

Read post
23 Jan 17
Antibacterial drugs market will hit $35.6 billion by 2022, as efforts increase to tackle antimicrobial resistance, says GBI Research

The antibacterial drugs market is set to grow from $27.7 billion in 2015 to $35.6 billion by 2022, representing a compound annual growth rate of 3.97%, according to business intelligence provider GBI Research.

Read post